Evidence map›Paper›PMID 24297382›Full record

ArticleAnnals of the rheumatic diseases2015

Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.

Catriona A Wagner, Jeremy Sokolove, Lauren J Lahey, Camilla Bengtsson, Saedis Saevarsdottir, Lars Alfredsson, Michelle Delanoy, Tamsin M Lindstrom, Roger P Walker, Reuven Bromberg and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Circulating Baseline CXCR3ACR open rheumatology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Catriona A WagnerGeriatric Research Education and Clinical Center (GRECC), Palo Alto, California, USA Division of Immunology and Rheumatology, Stanford University, Stanford, California, USA.
Jeremy SokoloveGeriatric Research Education and Clinical Center (GRECC), Palo Alto, California, USA Division of Immunology and Rheumatology, Stanford University, Stanford, California, USA.
Lauren J LaheyGeriatric Research Education and Clinical Center (GRECC), Palo Alto, California, USA Division of Immunology and Rheumatology, Stanford University, Stanford, California, USA.
Camilla BengtssonInstitute for Environmental Medicine, Karolinska Institutet, Stockhoom, Sweden.
Saedis SaevarsdottirRheumatology Unit, Department of Medicine and Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
Lars AlfredssonRheumatology Unit, Department of Medicine and Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
Michelle DelanoyBio-Rad Laboratories, Hercules, California, USA.
Tamsin M LindstromGeriatric Research Education and Clinical Center (GRECC), Palo Alto, California, USA Division of Immunology and Rheumatology, Stanford University, Stanford, California, USA.
Roger P WalkerBio-Rad Laboratories, Hercules, California, USA.
Reuven BrombergGeriatric Research Education and Clinical Center (GRECC), Palo Alto, California, USA Division of Immunology and Rheumatology, Stanford University, Stanford, California, USA.
Piyanka E ChandraGeriatric Research Education and Clinical Center (GRECC), Palo Alto, California, USA Division of Immunology and Rheumatology, Stanford University, Stanford, California, USA.
Steven R BinderBio-Rad Laboratories, Hercules, California, USA.
Lars KlareskogRheumatology Unit, Department of Medicine and Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
William H RobinsonGeriatric Research Education and Clinical Center (GRECC), Palo Alto, California, USA Division of Immunology and Rheumatology, Stanford University, Stanford, California, USA.
Geriatric Research Education and Clinical Center · USKarolinska Institutet · SEBio-Rad (United States) · USStanford University · US

Funding

Training Program in Adult and Pediatric RheumatologyT32AR050942 · NIAMS · STANFORD UNIVERSITY · PI LEWIS, DAVID BRAM, ROBINSON, WILLIAM H · 2005 to 2025
$6.6M
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid ArthritisU01AI101981 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 2012 to 2021
$6.2M
NHLBI PROTEOMICS INITIATIVE-N01HV28183N01HV028183 · HV · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2002 to 2006
–
NHLBI NIH HHS N01-HV-00242NHLBI NIH HHS N01 HV028183NIAID NIH HHS U01 AI101981NIAMS NIH HHS T32 AR050942
6 · The paper itself

Abstract

introductionA hallmark of rheumatoid arthritis (RA) is the development of autoantibodies targeting proteins that contain citrulline. Anticitrullinated protein antibodies (ACPAs) are currently detected by the commercial cyclic citrullinated peptide (CCP) assay, which uses a mix of cyclised citrullinated peptides as an artificial mimic of the true antigen(s). To increase the sensitivity of ACPA detection and dissect ACPA specificities, we developed a multiplex assay that profiles ACPAs by measuring their reactivity to the citrullinated peptides and proteins derived from RA joint tissue.

methodsWe created a bead-based, citrullinated antigen array to profile ACPAs. This custom array contains 16 citrullinated peptides and proteins detected in RA synovial tissues. We used the array to profile ACPAs in sera from a cohort of patients with RA and other non-inflammatory arthritides, as well as sera from an independent cohort of RA patients for whom data were available on carriage of HLA-DRB1 'shared epitope' (SE) alleles and history of cigarette smoking.

resultsOur multiplex assay showed that at least 10% of RA patients who tested negative in the commercial CCP assay possessed ACPAs. Carriage of HLA-DRB1 SE alleles and a history of cigarette smoking were associated with an increase in ACPA reactivity-in anti-CCP(+) RA and in a subset of anti-CCP(-) RA.

conclusionsOur multiplex assay can identify ACPA-positive RA patients missed by the commercial CCP assay, thus enabling greater diagnostic sensitivity. Further, our findings suggest that cigarette smoking and possession of HLA-DRB1 SE alleles contribute to the development of ACPAs in anti-CCP(-) RA.

Indexed as

AdolescentAdultAgedAllelesArthritis, PsoriaticArthritis, RheumatoidAutoantibodiesAutoantigensCase-Control StudiesCitrullineEnzyme-Linked Immunosorbent AssayEpitopesFemaleGoutHLA-DRB1 ChainsHumansAutoantibodiesAutoantigensCitrullinecyclic citrullinated peptideEpitopesHLA-DRB1 ChainsPeptidesPeptides, CyclicAutoantibodiesRheumatoid ArthritisSmoking

Identifiers

PMID24297382
PMCPMC4345988
OpenAlexW2121875491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.